NCT01380704View on ClinicalTrials.gov

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Major Depressive Disorder
Interventions
DRUG

ABT-436

QD Days 1-7

DRUG

Matching Placebo

QD Days 1-7

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY